)
)
Plus Therapeutics Investor Relations Material
Latest events
Q2 2024
Plus Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Plus Therapeutics Inc
Access all reports
Plus Therapeutics Inc is a clinical-stage pharmaceutical company, which develops, manufactures, and commercializes treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company was formerly known as Cytori Therapeutics Inc and changed its name to Plus Therapeutics Inc in July 2019. Plus Therapeutics Inc was founded in 1996 and is headquartered in Austin, Texas.
Latest articles
)
Cristiano Amon: Qualcomm's 5G Specialist CEO
Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.
16 Sep 2024
)
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Ticker symbol
PSTV
Country
🇺🇸 United States